J.W.G. van Putten

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands

Christine M. Cramer‐van der Welle, Marjon V. Verschueren, Merel Tonn et al. · Scientific Reports · 2021 · 110 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study

Bonne Biesma, A.N.M. Wymenga, Andrew Vincent et al. · Annals of Oncology · 2011 · 101 citations

Medicine, Geriatric Medicine, Oncology +17

Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose

Sharina Kort, Marjolein Brusse‐Keizer, Hugo Schouwink et al. · CHEST Journal · 2022 · 87 citations · Full text

Engineering, Oncology, Biosensors +11

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Karlijn de Joode, Daphne W. Dumoulin, Jolien Tol et al. · European Journal of Cancer · 2020 · 78 citations · Full text

Medicine, Oncology, Cancer Epidemiology +4

Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study

Harry J.M. Groen, A.H.W. van der Leest, Eelco Fokkema et al. · Annals of Oncology · 2004 · 68 citations

Medicine, Oncology, Pharmacology +13